Notes
Major events included major amputation, target limb repeat procedure or death
Only the direct costs of the primary intervention were included.
Reference
Katsanos K, et al. Cost-effectiveness analysis of infrapopliteal drug-eluting stents. Cardiovascular and Interventional Radiology 36: 90-97, No. 1, 1 Feb 2013. Available from: URL: http://dx.doi.org/10.1007/s00270-012-0370-8
Rights and permissions
About this article
Cite this article
Infrapopliteal DES use in limb ischaemia worth its cost. PharmacoEcon Outcomes News 673, 9 (2013). https://doi.org/10.1007/s40274-013-0216-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0216-x